Medicine & Life Sciences
Colorectal Neoplasms
100%
Rectal Neoplasms
63%
Capecitabine
41%
Neoplasms
28%
Fluorouracil
24%
Survival
24%
pembrolizumab
22%
Scotland
21%
Microsatellite Instability
21%
Irinotecan
19%
Neoadjuvant Therapy
18%
durvalumab
18%
Therapeutics
17%
Progression-Free Survival
14%
Leucovorin
14%
Anus Neoplasms
14%
Cetuximab
14%
Oxaliplatin
14%
Radiotherapy
13%
DNA Mismatch Repair
13%
Deep Learning
12%
vanucizumab
12%
MEHD7945A
11%
Mitomycin
11%
diflomotecan
11%
etirinotecan pegol
11%
Quality of Life
10%
Chemoradiotherapy
9%
Adenocarcinoma
9%
Biopsy
9%
perfluorooctanoic acid
8%
Adjuvant Chemotherapy
8%
Pharmacokinetics
7%
Gene Expression Profiling
7%
Coronary Vasospasm
7%
Maintenance Chemotherapy
7%
Bevacizumab
7%
Biomarkers
7%
Adjuvant Radiotherapy
7%
Lymph Node Ratio
7%
Margins of Excision
7%
Drug Therapy
7%
Ipilimumab
7%
Sleep Initiation and Maintenance Disorders
7%
Datasets
7%
Nivolumab
7%
Immunohistochemistry
6%
Mortality
6%
Sorafenib
6%
Diarrhea
6%